The effect of antidepressants on lipid homeostasis: a cardiac safety concern?

@article{McIntyre2006TheEO,
  title={The effect of antidepressants on lipid homeostasis: a cardiac safety concern?},
  author={R. McIntyre and J. Soczynska and J. Konarski and S. Kennedy},
  journal={Expert Opinion on Drug Safety},
  year={2006},
  volume={5},
  pages={523 - 537}
}
Objective: The authors sought to summarise and synthesise results from investigations which report on the effect of antidepressants on serum lipid homeostasis. Method: The authors conducted a MedLine search of all English-language articles from 1966 to March 2006 using the search terms: major depressive disorder, bipolar disorder, lipids, triglycerides, cholesterol, low-density lipoprotein, high-density lipoprotein, and the non-proprietary names of conventional antidepressants indicated for the… Expand
Comparing the effects of fluoxetine and imipramine on total cholesterol, triglyceride, and weight in patients with major depression
TLDR
Monitoring TC and TG and BW is recommended before starting imipramine in depressed patients with increased risk for cardiovascular disease, and fluoxetine may be the preferred agent in those with high or borderline high lipid levels. Expand
Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability
TLDR
Although recent meta-analyses suggest sertraline and escitalopram might have increased efficacy/tolerability, other studies and large pragmatic trials have not found these to be superior to other antidepressant drugs and no superior drug was identified in terms of cost-effectiveness. Expand
High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder
TLDR
It is observed for the first time in a clinical setting that a pharmacodynamic-based classification of antidepressants could be more useful than the traditional one to predict the risk of MetS in patients with bipolar disorder. Expand
Menopause symptom management in women with dyslipidemias: An EMAS clinical guide.
TLDR
This clinical guide is to provide an evidence-based approach to management of menopausal symptoms and dyslipidemia in postmenopausal women and evaluates the effects on the lipid profile both ofMenopausal hormone therapy and of non-estrogen-based treatments for menopausal Symptoms. Expand
Adverse reactions to duloxetine in depression
TLDR
Duloxetine was found to be well tolerated and can be safely administered even in older patients and in those with concomitant illnesses, and no increase in death from suicide and suicidal thoughts and behavior were detected as compared to placebo. Expand
Comparison of the effects of sertraline and agomelatine on sleep quality, sexual functioning and metabolic parameters in patients with major depressive disorder
TLDR
The favourable effects of agomelatine on sleep quality and the rapid onset of this effect may be beneficial in particular cases and sertraline may be an alternative drug for patients who complain of sexual side effects. Expand
Epidemiological link between low cholesterol and suicidality: A puzzle never finished
TLDR
The aim of this contribution is to comprehensively update and critically review the epidemiological evidences and to discussions of the direction and methodological challenges for future investigations. Expand
Importance of the Concept of Metabolic Syndrome in Psychiatry : Contribution of the Disease to Risk of Metabolic Syndrome
The concept of metabolic syndrome in psychiatry provides a united front for confronting a series of metabolic changes that are predictive of cardiovascular disease (CVD) and type 2 diabetes mellitusExpand
Desvenlafaxine succinate for the treatment of major depressive disorder
TLDR
DVS showed efficacy in clinical trials in MDD with doses ranging from 50 – 400 mg andvantages compared to other antidepressants include once daily dosing at effective doses, no CYP450 metabolism and low drug–drug interactions. Expand
Serum lipid levels in seasonal affective disorder
TLDR
The results of this study support the idea that low cholesterol levels may be of pathogenetic importance in SAD and larger clinical samples is warranted to clarify the findings. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 74 REFERENCES
The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms
TLDR
Some antidepressants exert a clinically significant effect on metabolism relevant to both therapeutic outcome and adverse events. Expand
Effect of mirtazapine treatment on body composition and metabolism.
TLDR
The antidepressant therapy with mirtazapine was associated with a significant increase in body weight, body fat mass, and leptin concentration, and in contrast to other psychotropic medications inducing weight gain, mirtzapine treatment did not influence the glucose homeostasis. Expand
The effects of mirtazapine on plasma lipid profiles in healthy subjects.
TLDR
The results suggest that while mirtazapine may be associated with increased TC, it does not increase LDL levels or affect the ratio of TC to HDL. Expand
Are mood disorders and obesity related? A review for the mental health professional.
TLDR
Although the overlap between mood disorders and obesity may be coincidental, it suggests the two conditions may be related. Expand
Are psychoactive-drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiatric disorders?
TLDR
It is hypothesized that an increase in plasma TC or LDL and/or a decrease in plasma TRI or VLDL may induce a relative decrease in brain cell membrane fluidity with decreased presynaptic serotonin reuptake and increased postsynaptic serotonin function. Expand
Lipid metabolism and insulin resistance in depressed patients: significance of weight, hypercortisolism, and antidepressant treatment.
TLDR
Treatment of depression exerts a mainly beneficial effect on lipid regulation, and the inverse correlation of cortisol and cholesterol, at least in the obese subgroup, proposes a mechanism for the known association of depression with low cholesterol. Expand
Use of antidepressants in treatment of comorbid diabetes mellitus and depression as well as in diabetic neuropathy.
  • P. Goodnick
  • Medicine
  • Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists
  • 2001
TLDR
In comorbid diabetes mellitus and depression, most evidence supports the use of fluoxetine in control of glucose handling and other characteristics in terms dosing, drug interactions, cognition, and sleep make sertraline an attractive alternative agent. Expand
Imipramine Treatment and Increased Serum Cholesterol Levels
TLDR
This is the first report in humans suggesting that treatment with TCAs may be associated with some increase in serum cholesterol levels, and this is in agreement with an earlier study done with rabbits. Expand
Treatment of depression in patients with diabetes mellitus.
TLDR
Depression is frequent among diabetic patients and impairs diabetic management, and one should consider the SSRIs in preference over the TCAs to maximize response of both depression and diabetic disorder. Expand
The Association of Low Serum Cholesterol with Depression and Suicidal Behaviours: New Hypotheses for the Missing Link
TLDR
The available evidence does not seem to substantiate the view that large-scale intervention to reduce cholesterol concentrations could lead to more violent and aggressive behaviour, and generally greater unhappiness, and clinicians should not be deterred from prescribing cholesterol-lowering drugs, to reduce the risk of death from coronary heart disease, when they are indicated. Expand
...
1
2
3
4
5
...